These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Disorder of the leukocytic defense function as a paraneoplastic syndrome in hemoblastoses]. Senn HJ; Rhomberg WU; Jungi WF Schweiz Med Wochenschr; 1971 Apr; 101(13):466-70. PubMed ID: 5283772 [No Abstract] [Full Text] [Related]
6. [Functional evaluation of the defense against infection in leukemias]. Senn HJ; Holland JF Schweiz Med Wochenschr; 1970 Feb; 100(7):308-10. PubMed ID: 4984093 [No Abstract] [Full Text] [Related]
8. Anti--DNA antibodies in patients with leukemia and lymphoma. Izui S; Lambert PH; Carpentier NA; Miescher PA Schweiz Med Wochenschr; 1976 Oct; 106(40):1377-8. PubMed ID: 1087460 [TBL] [Abstract][Full Text] [Related]
9. The role of the phagocyte in host-parasite interactions. 3. The phagocytic capabilities of leukocytes from myeloproliferative and other neoplastic disorders. Sbarra AJ; Shirley W; Selvaraj RJ; McRipley RJ; Rosenbaum E Cancer Res; 1965 Sep; 25(8):1199-206. PubMed ID: 5214691 [No Abstract] [Full Text] [Related]
10. Studies of red cell isoantigens on peripheral leukocytes from normal and leukemic individuals. Kassulke JT; Hallgren HM; Yunis EJ Am J Pathol; 1969 Sep; 56(3):333-49. PubMed ID: 5258866 [No Abstract] [Full Text] [Related]
11. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies]. Berceanu S; Gociu M Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583 [No Abstract] [Full Text] [Related]
12. The metabolic activities of leukocytes from lymphoproliferative and myeloproliferative disorders during phagocytosis. Selvaraj J; McRipley RJ; Sbarra AJ Cancer Res; 1967 Dec; 27(12):2287-94. PubMed ID: 5237348 [No Abstract] [Full Text] [Related]
13. [Counting of leukocytes effective for the prevention of infection in leukemias by counting leukocytes in the saliva]. Stobbe H; Zimmermann I; Strecker B Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):347-52. PubMed ID: 4139054 [No Abstract] [Full Text] [Related]
14. Immunofluorescent studies of human leukemic cells with antiserum to a murine leukemic virus (Rauscher strain). Ioannides AK; Rosner F; Brenner M; Lee SL Blood; 1968 Mar; 31(3):381-7. PubMed ID: 4966600 [No Abstract] [Full Text] [Related]
15. [Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases]. Loni C; Ricci S; Azzarà A; Bertoncini G Quad Sclavo Diagn; 1984 Jun; 20(2):193-202. PubMed ID: 6441963 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the mixed leucocyte reaction by target cell death: a study of leukaemic cells. Pegrum GD; Evans CA; Middleton VL; Balfour IC Clin Exp Immunol; 1972 Feb; 10(2):251-6. PubMed ID: 4505586 [TBL] [Abstract][Full Text] [Related]
17. Studies on the cellular composition of sterile skin exudate in proliferative diseases of the hemopoietic system. Kowal E Pol Med J; 1969; 8(4):824-30. PubMed ID: 4936481 [No Abstract] [Full Text] [Related]
18. [Immunological classification of lymphoproliferative conditions]. Froland SS Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2220-3. PubMed ID: 4531116 [No Abstract] [Full Text] [Related]